UNPACKING THE ROLE OF NEOANTIGENS AND TUMOR MUTATIONAL BURDEN IN CANCER IMMUNOTHERAPY
Alexander James Chen · January 2025 · pp. 1-12
Cancer immunotherapy has revolutionized oncology by leveraging the immune system to combat tumors. Among various biomarkers, neoantigens and tumor mutational burden (TMB) have emerged as critical factors in tailoring personalized...